Authors:
Toussaint, B
Palmer, M
Chiap, P
Hubert, P
Crommen, J
Citation: B. Toussaint et al., On-line coupling of partial filling-capillary zone electrophoresis with mass spectrometry for the separation of clenbuterol enantiomers, ELECTROPHOR, 22(7), 2001, pp. 1363-1372
Authors:
Klein, M
Vignaud, JM
Hennequin, V
Toussaint, B
Bresler, L
Plenat, F
Leclere, J
Duprez, A
Weryha, G
Citation: M. Klein et al., Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma, J CLIN END, 86(2), 2001, pp. 656-658
Citation: D. Dacheux et al., Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates, INFEC IMMUN, 69(1), 2001, pp. 538-542
Authors:
Toussaint, B
Pitti, C
Streel, B
Ceccato, A
Hubert, P
Crommen, J
Citation: B. Toussaint et al., Quantitative analysis of N-acetylcysteine and its pharmacopeial impuritiesin a pharmaceutical formulation by liquid chromatography-UV detection-massspectrometry, J CHROMAT A, 896(1-2), 2000, pp. 191-199
Authors:
Toussaint, B
Streel, F
Ceccato, A
Hubert, P
Crommen, J
Citation: B. Toussaint et al., Determination of the enantiomers of 3-tert.-butylamino-1,2-propanediol by high-performance liquid chromatography using mass spectrometric detection, J CHROMAT A, 896(1-2), 2000, pp. 201-207
Authors:
Toussaint, B
Duchateau, ALL
van der Wal, S
Albert, A
Hubert, P
Crommen, J
Citation: B. Toussaint et al., Determination of the enantiomers of 3-tert.-butylamino-1,2-propanediol by high-performance liquid chromatography coupled to evaporative light scattering detection, J CHROMAT A, 890(2), 2000, pp. 239-249
Authors:
Toussaint, B
Hubert, P
Tjaden, UR
van der Greef, J
Crommen, J
Citation: B. Toussaint et al., Enantiomeric separation of clenbuterol by transient isotachophoresis-capillary zone electrophoresis-UV detection - New optimization technique for transient isotachophoresis, J CHROMAT A, 871(1-2), 2000, pp. 173-180
Authors:
Lapeyre, M
Hoffstetter, S
Peiffert, D
Guerif, S
Maire, F
Dolivet, G
Toussaint, B
Mundt, A
Chassagne, JF
Simon, C
Bey, P
Citation: M. Lapeyre et al., Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins, INT J RAD O, 48(1), 2000, pp. 37-42
Authors:
Toussaint, B
Duchateau, ALL
van der Wal, S
Albert, A
Hubert, P
Crommen, J
Citation: B. Toussaint et al., Comparative evaluation of four detectors in the high-performance liquid chromatographic analysis of chiral nonaromatic alcohols, J CHROM SCI, 38(10), 2000, pp. 450-457
Authors:
Dacheux, D
Toussaint, B
Richard, M
Brochier, G
Croize, J
Attree, I
Citation: D. Dacheux et al., Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils, INFEC IMMUN, 68(5), 2000, pp. 2916-2924
Authors:
Polack, B
Vergnaud, S
Paclet, MH
Lamotte, D
Toussaint, B
Morel, F
Citation: B. Polack et al., Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease, BIOC BIOP R, 275(3), 2000, pp. 854-858
Authors:
Ceccato, A
Toussaint, B
Chiap, P
Hubert, P
Crommen, J
Citation: A. Ceccato et al., Automated sample preparation techniques for the determination of drug enantiomers in biological fluids using liquid chromatography with chiral stationary phases, ENANTIOMER, 4(3-4), 1999, pp. 305-315
Citation: R. Lambert et al., LAI evolution of a perennial ryegrass crop estimated from the sum of temperatures in spring time, AGR FOR MET, 97(1), 1999, pp. 1-8
Authors:
Klein, M
Picard, E
Vignaud, JM
Marie, B
Bresler, L
Toussaint, B
Weryha, G
Duprez, A
Leclere, J
Citation: M. Klein et al., Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma, J ENDOCR, 161(1), 1999, pp. 41-49
Authors:
Dacheux, D
Attree, I
Schneider, C
Toussaint, B
Citation: D. Dacheux et al., Cell death of human polymorphonuclear neutrophils induced by a Pseudomonasaeruginosa cystic fibrosis isolate requires a functional type III secretion system, INFEC IMMUN, 67(11), 1999, pp. 6164-6167